| EEMDX | RNWAX | EEMDX / RNWAX | |
| Total Expense Ratio | 2.06 | 1.66 | 124% |
| Annual Report Gross Expense Ratio | 10.84 | 1.66 | 653% |
| Fund Existence | 5 years | 24 years | - |
| Gain YTD | 19.024 | 13.362 | 142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.46M | 90.7B | 0% |
| Annual Yield % from dividends | 0.87 | 0.50 | 175% |
| Returns for 1 year | 33.61 | 20.44 | 164% |
| Returns for 3 years | 58.51 | 39.97 | 146% |
| Returns for 5 years | 35.83 | 12.95 | 277% |
| Returns for 10 years | N/A | 98.52 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IEMFX | 49.12 | 1.01 | +2.10% |
| T. Rowe Price Instl Emerging Mkts Eq | |||
| SPFZX | 34.59 | 0.43 | +1.26% |
| PGIM Jennison Focused Growth Z | |||
| MAIJX | 21.76 | 0.10 | +0.46% |
| Morgan Stanley Inst Passport ovrs eq R6 | |||
| LRAGX | 20.02 | 0.08 | +0.40% |
| Lord Abbett International Growth R3 | |||
| SHISX | 61.73 | -0.68 | -1.09% |
| BlackRock Health Sciences Opps Svc | |||